GH Research PLC

General ticker "GHRS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $821.5M (TTM average)

GH Research PLC follows the US Stock Market performance with the rate: 50.9%.

Estimated limits based on current volatility of 3.4%: low 23.62$, high 25.28$

Factors to consider:

  • Total employees count: 14 as of 2021
  • Current price 26.4% above estimated high
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [8.62$, 19.33$]
  • 2026-12-31 to 2027-12-31 estimated range: [7.61$, 17.42$]

Financial Metrics affecting the GHRS estimates:

  • Negative: with PPE of -15.9 at the end of fiscal year the price was high
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Shareholder equity ratio, % of 97.04 > 64.29
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Interest expense per share per price, % of 0.06 <= 0.73
  • Positive: Investing cash flow per share per price, % of 5.94 > -0.60

Similar symbols

Short-term GHRS quotes

Long-term GHRS plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $41.22MM $50.31MM $60.68MM
Operating Income $-41.22MM $-50.31MM $-60.68MM
Non-Operating Income $5.63MM $11.35MM $12.42MM
Interest Expense $0.72MM $0.72MM $0.46MM
R&D Expense $29.82MM $35.02MM $38.73MM
Income(Loss) $-35.59MM $-38.96MM $-48.26MM
Net Income(Loss)* $-35.59MM $-38.96MM $-48.26MM
Stockholders Equity $218.97MM $178.95MM $279.70MM
Assets $226.30MM $188.27MM $288.23MM
Operating Cash Flow $-33.34MM $-42.28MM $-43.55MM
Capital expenditure $0.10MM $0.05MM $0.12MM
Investing Cash Flow $-54.10MM $65.14MM $46.17MM
Financing Cash Flow $-0.20MM $-0.30MM $139.65MM
Earnings Per Share** $-0.68 $-0.75 $-0.79

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.